Everybody hates the iron ore rally

Advertisement

Following in my footsteps, the AFR has a good piece today from Deutsche’s Adam Boyton on the both the importance and price of iron ore:

…if iron ore prices were to hold at the $US158 a tonne level seen a little over a week ago, interest rates could end the year higher than they are now – not lower, as markets currently expect.

On our estimates, an iron ore price of $US158 a tonne throughout the year would see a sharp pick-up in nominal GDP growth to around 6 per cent by the end of 2013…This is because it measures not just what the economy is producing, but also what we are being paid for it. A 6 per cent pace of growth in nominal GDP is above what Treasury would consider to be Australia’s long-run average growth rate…So iron ore could rescue the Australian economy. However, weakness at the start of the financial year means that nominal GDP growth in 2012-13 would still fall a little over a percentage point short of the government’s current forecast of 4 per cent.

We expect that this seasonal pattern, as well as additional supply from Australia and Brazil, could see iron ore back under $US120 a tonne around the middle of the year.

Spot on, I say. This seems an opportune time to check in on what other analysts are forecasting for iron ore and here you have it:

Advertisement

A median price of $118.50 and falling thereafter. Some of these are out of date, though, Mark Pervan of ANZ cut his forecasts to $115 for Q1 in October. Nobody trusts the rally.

About the author
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal. He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.